Fortrea Holdings Inc. (FTRE) stock
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3056% above fair value
$19.59−0.20 (-1.01%)
Close on Nov 17, 2026Market cap $1.89BP/E –Yield –
Fortrea r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Fortrea
Fortrea has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?